Sobel, 2017 - Google Patents

Bacterial vaginosis

Sobel, 2017

Document ID
10971776172715370854
Author
Sobel J
Publication year
Publication venue
Sexually Transmitted Infections in HIV-Infected Adults and Special Populations: A Clinical Guide

External Links

Snippet

Bacterial vaginosis (BV) is widely prevalent, frequently associated with chronicity and high rates of recurrence and is particularly common in women with HIV infection, adding yet another burden to successful therapy and quality of life. Anything but a nuisance infection …
Continue reading at link.springer.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells

Similar Documents

Publication Publication Date Title
Abou Chacra et al. Bacterial vaginosis: what do we currently know?
Abdul-Aziz et al. Bacterial vaginosis, vulvovaginal candidiasis and trichomonal vaginitis among reproductive-aged women seeking primary healthcare in Sana’a city, Yemen
Sobel What's new in bacterial vaginosis and trichomoniasis?
Sha et al. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis
Jamieson et al. Longitudinal analysis of bacterial vaginosis: findings from the HIV epidemiology research study
Sobel Bacterial vaginosis
Giraldo et al. Vaginal colonization by Candida in asymptomatic women with and without a history of recurrent vulvovaginal candidiasis
Thurman et al. Bacterial vaginosis and subclinical markers of genital tract inflammation and mucosal immunity
Mashburn Etiology, diagnosis, and management of vaginitis
Wang et al. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1
Sturm-Ramirez et al. High levels of tumor necrosis factor—α and interleukin-1β in bacterial vaginosis may increase susceptibility to human immunodeficiency virus
Nelson et al. Bacterial vaginosis in pregnancy: current findings and future directions
Eckert et al. The antimicrobial treatment of subacute endometritis: a proof of concept study
BELL et al. Sexually transmitted diseases in females in a juvenile detention center
Dunne et al. Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV-and HSV-2-infected women, Chiang Rai, Thailand
Eschenbach et al. Effects of vaginal intercourse with and without a condom on vaginal flora and vaginal epithelium
Neal et al. Noncandidal vaginitis: a comprehensive approach to diagnosis and management
Farage et al. Determining the cause of vulvovaginal symptoms
Stevens-Simon et al. Racial variation in vaginal pH among healthy sexually active adolescents
Warren et al. A multicenter study of bacterial vaginosis in women with or at risk for human immunodeficiency virus infection
Marrazzo Mucopurulent cervicitis: no longer ignored, but still misunderstood
Thinkhamrop et al. Vaginal fluid pH as a screening test for vaginitis
Paz-Bailey et al. Determinants of HIV type 1 shedding from genital ulcers among men in South Africa
Cromwell et al. Prevalence and incidence of pelvic inflammatory disease in incarcerated adolescents
Ifeanyi et al. Trichomonas vaginalis: complications and treatment